The Emerging Role of Telemedicine in Managing Glycemic Control and Psychobehavioral Aspects of Pregnancy Complicated by Diabetes

Table 1

Brief summary of the main outcomes of the studies conducted in pregnant women with type 1 diabetes.

	Wójcicki et al. [3]	Ładyżyński et al. [4]	Ładyżyński and Wójcicki [5]	Di Biase et al. [6]	Frost and Beischer [7]	Dalfrà et al. [8]
Number of participants (interv./control)	15/15	15/nv	15/15	10/10	11/10	17/15
Duration of monitoring (days ± SD; interv./control)	180 ± 21.9/176 ± 16.4	166 ± 24	180 ± 22/176 ± 16.4	Variable between groups	158 ± 41/188 ± 32	167 ± 27/160 ± 63
Subjects training (interv./control)	Telematic ICS/RAV	PTM and CCU/nv	HTS/CE every 3 weeks	DIANET system/RAV	CareLink system/RAV	Glucobeep system/CE every 2 weeks
Clinical outcome (metabolic/QoL)	+/nv	+/nv	=/+	+/nv	+/nv	=/+
Behavioural outcome	nv	+	nv	nv	nv	+
Care coordination outcome	nv	nv	nv	nv	nv	nv

For more details about the clinical, behavioral, and care coordination outcomes, refer to Verhoeven et al. [9].
QoL: quality of life; SD: standard deviation; nv: not valued; ICS: intensive care system; RAV: regular ambulatory visits; PTM: patient teletransmission module; CCU: central clinical control unit; HTS: home telecare system; CE: clinical examinations.